Table 1.
Characteristics | Current Study n=12 527 | Not in Current Study n=5275 | Overall Study n=17 802 |
---|---|---|---|
Age, y | 66 (60–71) | 66 (61–71) | 66 (60–71) |
Female | 4542 (36.3) | 2259 (42.8) | 6801 (38.2) |
Rosuvastatin | 6182 (49.4) | 2719 (51.6) | 8901 (50.0) |
Race/ethnicity | |||
White | 10 251 (81.8) | 2432 (46.1) | 12 683 (71.3) |
Black | 886 (7.1) | 1338 (25.4) | 2224 (12.5) |
Asian | 184 (1.5) | 99 (1.9) | 283 (1.6) |
Hispanic | 1105 (8.8) | 1156 (21.9) | 2261 (12.7) |
Other/unknown | 99 (0.8) | 250 (4.7) | 349 (2.0) |
Body mass index, kg/m2 | 28.4 (25.5–32.0) | 28.1 (25.0–32.0) | 28.4 (25.3–32.) |
Systolic blood pressure, mmHg | 134 (124–146) | 134 (125–144) | 134 (124–145) |
Diastolic blood pressure, mmHg | 80 (75–86) | 80 (76–89) | 80 (75–87) |
Current smoker | 1883 (15.0) | 937 (17.8) | 2820 (15.9) |
Family history of premature coronary disease | 1575 (12.6) | 470 (9.0) | 2045 (11.5) |
Metabolic syndrome | 4987 (40.4) | 2329 (44.5) | 7316 (41.6) |
Fasting glucose, mg/dL | 95 (88–102) | 93 (86–101) | 94 (88–102) |
Hemoglobin A1c, % | 5.7 (5.4–5.9) | 5.7 (5.5–6.0) | 5.7 (5.5–5.9) |
High‐sensitivity C‐reactive protein, mg/L | 4.1 (2.8–6.9) | 4.7 (3.0–7.9) | 4.3 (2.9–7.1) |
LDL cholesterol, mg/dL | 109 (95–119) | 107 (91–118) | 108 (94–119) |
Total cholesterol, mg/dL | 186 (170–200) | 183 (165–198) | 185 (169–200) |
Triglycerides, mg/dL | 116 (84–167) | 122 (88–175) | 118 (85–169) |
HDL cholesterol, mg/dL | 49 (41–60) | 47 (39–58) | 49 (40–60) |
Values stated are median (25th–75th percentile) or n (%). Percentages may not add up because of rounding off. HDL indicates high‐density lipoprotein; LDL, low‐density lipoprotein.